Perbandingan Proporsi Antibodi Ireguler pada Pasien Multitransfusi dan Pasien Non Multitransfusi di UTD RSUP Dr. Mohammad Hoesin Palembang

Comparison of the Proportion of Iregular Antibodies in Multitransfusion and Non Multitransfusion Patients at UTD RSUP Dr. Mohammad Hoesin Palembang

Keywords: Iregular antibody, Antibody Identification, Multitransfusion

Abstract

Irregular antibodies or "unexpected antibodies" are antibodies other than antibody A and antibody B that can occur due to pregnancy and blood transfusions. Patients who frequently perform transfusions (multitransfusions) are more at risk of forming irregular antibodies because the frequency of exposure to donor red blood cell antigens is more frequent. Irregular antibodies are clinically significant because they can cause hemolysis (erythrocyte alloantibodies), febrile non-hemolytic transfusion reactions (leukocyte alloantibodies), or refractory platelet transfusions (platelet alloantibodies). This research aims to compare the proportion of irregular antibodies in multitransfusion patients and non-multi transfused patients at UTD Dr. Mohammad Hoesin Palembang. This research is an analytic observational study with a cross-sectional design conducted on 2 groups of subjects, 45 each sample. Antibody identification in each group was carried out. Chi-Square analyzed the proportion of irregular antibodies. An analysis of the types of antibodies found and the accompanying clinical diagnoses were carried out. This study showed a significant difference in the proportion of irregular antibodies between the multitransfusion and non-multitransfusion groups with a p-value of 0.001. The types of irregular antibodies found anti-c, Fya, Lea, M, Kpa, LubkKpb, and the clinical diagnoses that found irregular antibodies were anemia, thalassemia, and AIHA.

Downloads

Download data is not yet available.

References

1. Brecher, M.E. 2005. Technical Manual 15th. American Association of Blood Banks (AABB). US. p. 483-520.
2. Chou ST, Liem RI, Thompson AA. 2012.Challenges of alloimmunization in patients with haemoglobinopathies. Br J Haematol. Nov;159(4):394-404.
3. Dean, Laura M.D. 2005. Blood Groups and Red Cell Antigens. National Center for Biotechnology Information (NCBI).
4. Fridawati V, Triyono T, Sukorini U. 2016. Faktor Kebahayaan Terbentuknya Alloantibodi pada Pasien Talasemia yang Menerima Transfusi Darah Berulang. Indonesian Journal of Clinical Pathology and Medical Laboratory IJCPML; 20 (3);116-130. https://indonesianjournalofclinicalpathology.or
5. Irfannuddin, 2019. Cara Sistematis Berlatih Meneliti. Edisi Pertama. Rayana Komunikasindo. Jakarta.
6. Jungbauer C, Hobel CM, Schwartz DWM, Mayr WR. 2012. High-throughtput multiplex PCR genotyping for 35 red blood cell antigens in blood donors. Vox Sang;102(3):234-42.https://onlinelibrary.wiley.com.
7. Merizka E. 2016. Profil Antigen Sel Darah Merah dan Aloantibodi pada Pasien Talasemia di Pusat Talasemia Rumah Sakit Dr. Ciptomangunkusumo (RSCM) Program Studi Magister Ilmu Biomedik.
8. Ness, PM. 2000. Transfusion Medicine: An Overview and Update.ClinChem;46(8 Pt 2):1270-6. https://pubmed.ncbi.nlm.nih.gov
9. Ningrum NR, Ritchie NK, Syafitri R. 2018. Skrining dan Identifikasi Antibodi Pasien di UTD PMI. Pinlitamas. Jakarta.
10. Novelli EM. 2017. Blood Transfusion in the Management of Patients with Haemoglobinopathies. In: Murphy MF, Rob-erts DJ, Yazer MH. Practical Transfusion Medicine. 5 th p. 330-8.
11. Perwitasari E, Dalimonthe NZ, Lismayanti L, Andiyoko B. 2017. Gambaran Hasil Screening Aloantibodi pada Pasien Tranfusion Dependent Thalassemia di RSUP Dr. Hasan Sadikin Bandung. Fakultas Kedokteran Universitas Padjajaran. Bandung
12. Reid ME, Lomas FC. 2016. Erythrocyte Antigens and Antibodies In: Kaushansky K, Lichtman MA, Prchal JT, Levi MM, Press OW, Burns LJ, et al. William HematologyNineth Edition. McGraw-Hill Education. New York. p. 2329-51.
13. Reid, M. E. 2003. The Dombrock blood group system: a review. Transfusion, 43(1), 107–114. doi:10.1046/j.1537-2995.2003.00283.x
14. Rikesdas. 2018. Laporan Hasil Riset Kesehatan Dasar. Balitbangkes. Jakarta
15. Trudell, KS. 2014. Detection and Identification of Antibodies. In: Harmening, DM. Modern Blood Banking & Transfusion Practices 6th.US. p. 216-240.
16. WHO, 2009. Detection and identification of antibodies. Safe Blood and Blood Product.WHO.Genewa. p. 38-44. https://www.who.int/bloodsafety/transfusion.pdf
17. Wilkins, R. 2011. Antibody Identification. School of Health Related Proffesions, University of Missisipi Medical Center. https://austincc.edu
18. Zwaginga JJ, Ham SMv. 2017. Essential Immunology for Trans-fusion Medicine. In: Murphy MF, Roberts DJ, Yazer MH. Practical Transfusion Medicine 5 th p. 11-8.
Published
2021-08-30
How to Cite
Amalia, A., Hafy, Z., & Liana, P. (2021). Perbandingan Proporsi Antibodi Ireguler pada Pasien Multitransfusi dan Pasien Non Multitransfusi di UTD RSUP Dr. Mohammad Hoesin Palembang. Jurnal Surya Medika (JSM), 7(1), 9-14. https://doi.org/10.33084/jsm.v7i1.2630